Abstract
Rapid and affordable tumor molecular profiling has led to an explosion of clinical and genomic data poised to enhance the diagnosis, prognostication and treatment of cancer. A critical point has now been reached at which the analysis and storage of annotated clinical and genomic information in unconnected silos will stall the advancement of precision cancer care. Information systems must be harmonized to overcome the multiple technical and logistical barriers to data sharing. Against this backdrop, the Global Alliance for Genomic Health (GA4GH) was established in 2013 to create a common framework that enables responsible, voluntary and secure sharing of clinical and genomic data. This Perspective from the GA4GH Clinical Working Group Cancer Task Team highlights the data-aggregation challenges faced by the field, suggests potential collaborative solutions and describes how GA4GH can catalyze a harmonized data-sharing culture.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
Scientific Reports Open Access 12 March 2021
-
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Nature Genetics Open Access 03 April 2020
-
Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia
Human Genetics Open Access 17 September 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
McCarthy, M. US president endorses “moonshot” effort to cure cancer. Br. Med. J. 352, i213 (2016).
Collins, F.S. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 372, 793–795 (2015).
Siva, N. UK gears up to decode 100,000 genomes from NHS patients. Lancet 385, 103–104 (2015).
Meric-Bernstam, F. et al. Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials. J. Clin. Oncol. 33, 2753–2762 (2015).
André, F. et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol. 15, 267–274 (2014).
Walport, M. & Brest, P. Sharing research data to improve public health. Lancet 377, 537–539 (2011).
Joly, Y., Dove, E.S., Knoppers, B.M., Bobrow, M. & Chalmers, D. Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). PLoS Comput. Biol. 8, e1002549 (2012).
Rehm, H.L. et al. & ClinGen—the Clinical Genome Resource. N. Engl. J. Med. 372, 2235–2242 (2015).
US National Institutes of Health. National Institutes of Health genomic data sharing policy https://gds.nih.gov/PDF/NIH_GDS_Policy.pdf (27 August 2014).
Cancer Genome Atlas Research Network. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113–1120 (2013).
International Cancer Genome Consortium. et al. International network of cancer genome projects. Nature 464, 993–998 (2010).
Aparicio, S. & Caldas, C. The implications of clonal genome evolution for cancer medicine. N. Engl. J. Med. 368, 842–851 (2013).
Alizadeh, A.A. et al. Toward understanding and exploiting tumor heterogeneity. Nat. Med. 21, 846–853 (2015).
Köhler, S. et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res. 42, D966–D974 (2014).
Groza, T. et al. The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease. Am. J. Hum. Genet. 97, 111–124 (2015).
Girdea, M. et al. PhenoTips: patient phenotyping software for clinical and research use. Hum. Mutat. 34, 1057–1065 (2013).
Hamosh, A. et al. PhenoDB: a new web-based tool for the collection, storage, and analysis of phenotypic features. Hum. Mutat. 34, 566–571 (2013).
Denny, J.C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102–1111 (2013).
McCarty, C.A. et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 4, 13 (2011).
Schilsky, R.L., Michels, D.L., Kearbey, A.H., Yu, P.P. & Hudis, C.A. Building a rapid learning health care system for oncology: the regulatory framework of CancerLinQ. J. Clin. Oncol. 32, 2373–2379 (2014).
Sioutos, N. et al. NCI Thesaurus: a semantic model integrating cancer-related clinical and molecular information. J. Biomed. Inform. 40, 30–43 (2007).
Stein, L.D., Knoppers, B.M., Campbell, P., Getz, G. & Korbel, J.O. Data analysis: Create a cloud commons. Nature 523, 149–151 (2015).
Van Allen, E.M. et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat. Med. 20, 682–688 (2014).
Andre, F. et al. Prioritizing targets for precision cancer medicine. Ann. Oncol. 25, 2295–2303 (2014).
Kosseim, P. et al. Building a data sharing model for global genomic research. Genome Biol. 15, 430 (2014).
Paten, B. et al. The NIH BD2K center for big data in translational genomics. J. Am. Med. Inform. Assoc. 22, 1143–1147 (2015).
Boutros, P.C. et al. Global optimization of somatic variant identification in cancer genomes with a global community challenge. Nat. Genet. 46, 318–319 (2014).
Ewing, A.D. et al. & ICGC–TCGA DREAM Somatic Mutation Calling Challenge participants. Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection. Nat. Methods 12, 623–630 (2015).
Gargis, A.S. et al. Good laboratory practice for clinical next-generation sequencing informatics pipelines. Nat. Biotechnol. 33, 689–693 (2015).
Lawler, M. et al. & Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH). All the world's a stage: facilitating discovery science and improved cancer care through the global alliance for genomics and health. Cancer Discov. 5, 1133–1136 (2015).
Tryka, K.A. et al. NCBI's Database of Genotypes and Phenotypes: dbGaP. Nucleic Acids Res. 42, D975–D979 (2014).
Global Alliance for Genomics and Health. White Paper: creating a global alliance to enable responsible sharing of genomic and clinical data https://genomicsandhealth.org/about-the-global-alliance/key-documents/white-paper-creating-global-alliance-enable-responsible-shar (3 June 2013).
Kaye, J. The tension between data sharing and the protection of privacy in genomics research. in Ethics, Law and Governance of Biobanking, Vol. 14 (ed. Mascalzoni, D.) 101–120 (Springer, the Netherlands, 2015).
Haga, S.B. & Beskow, L.M. Ethical, legal, and social implications of biobanks for genetics research. Adv. Genet. 60, 505–544 (2008).
Wolf, L.E. & Lo, B. Untapped potential: IRB guidance for the ethical research use of stored biological materials. IRB 26, 1–8 (2004).
Lunshof, J.E., Chadwick, R., Vorhaus, D.B. & Church, G.M. From genetic privacy to open consent. Nat. Rev. Genet. 9, 406–411 (2008).
Lolkema, M.P. et al. Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology. J. Clin. Oncol. 31, 1842–1848 (2013).
O'Doherty, K.C. et al. From consent to institutions: designing adaptive governance for genomic biobanks. Soc. Sci. Med. 73, 367–374 (2011).
Zika, E., Schulte In den Bäumen, T., Kaye, J., Brand, A. & Ibarreta, D. Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics 9, 773–781 (2008).
Homer, N. et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet. 4, e1000167 (2008).
Lin, Z., Owen, A.B. & Altman, R.B. Genetics. Genomic research and human subject privacy. Science 305, 183 (2004).
Gymrek, M., McGuire, A.L., Golan, D., Halperin, E. & Erlich, Y. Identifying personal genomes by surname inference. Science 339, 321–324 (2013).
Erlich, Y. & Narayanan, A. Routes for breaching and protecting genetic privacy. Nat. Rev. Genet. 15, 409–421 (2014).
Knoppers, B.M. International ethics harmonization and the global alliance for genomics and health. Genome Med. 6, 13 (2014).
Knoppers, B.M., Harris, J.R., Budin-Ljøsne, I. & Dove, E.S. A human rights approach to an international code of conduct for genomic and clinical data sharing. Hum. Genet. 133, 895–903 (2014).
Global Alliance for Genomics and Health. Framework for responsible sharing of genomic and health-related data https://genomicsandhealth.org/node/6611 (10 September 2014).
Global Alliance for Genomics and Health. Consent policy https://genomicsandhealth.org/consent-policy-pdf-27-may-2015 (27 May 2015).
Global Alliance for Genomics and Health. GA P3G–IPAC consent tools https://genomicsandhealth.org/ga-p3g-ipac-consent-tools (6 August 2014).
Global Alliance for Genomics and Health. Privacy and security policy https://genomicsandhealth.org/privacy-and-security-policy-pdf-26-may-2015 (26 May 2015).
Global Alliance for Genomics and Health. Data sharing lexicon. https://genomicsandhealth.org/files/public/GA4GH_DataSharingLexicon_Mar15.pdf (15 March 2016).
Global Alliance for Genomics and Health. Security infrastructure: standards and implementation practices for protecting the privacy and security of shared genomic and clinical data https://genomicsandhealth.org/security-infrastructure-version-11 (12 March 2015).
Global Alliance for Genomics and Health. Accountability policy https://genomicsandhealth.org/ga4gh-accountability-policy (10 February 2016).
Christensen, K.D. et al. & MedSeq Project Team. Are physicians prepared for whole genome sequencing? a qualitative analysis. Clin. Genet. 89, 228–234 (2016).
Pillai, U. et al. Factors that may influence the willingness of cancer patients to consent for biobanking. Biopreserv. Biobank. 12, 409–414 (2014).
Mancini, J. et al. Consent for biobanking: assessing the understanding and views of cancer patients. J. Natl. Cancer Inst. 103, 154–157 (2011).
Tejpar, S. et al. Awareness and understanding of stratified/personalized medicine in patients treated for cancer: a multi-national survey (37th European Society for Medical Oncology Congress) 1382P (Oxford University Press, 2012).
Rogith, D. et al. Attitudes regarding privacy of genomic information in personalized cancer therapy. J. Am. Med. Inform. Assoc. 21, e2, e320–e325 (2014).
Lawler, M. et al. & European Cancer Concord (ECC). A Bill of Rights for patients with cancer in Europe. Lancet Oncol. 15, 258–260 (2014).
Lawler, M. et al. A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist 19, 217–224 (2014).
European Commission. Proposal for a regulation of the European Parliament and of the council on the protection of individuals with regard to processing of personal data and on the free movement of such data (general data protection regulation) http://ec.europa.eu/justice/data-protection/document/review2012/com_2012_11_en.pdf, (25 January 2012).
Husedzinovic, A., Ose, D., Schickhardt, C., Fröhling, S. & Winkler, E.C. Stakeholders' perspectives on biobank-based genomic research: systematic review of the literature. Eur. J. Hum. Genet. 23, 1607–1614 (2015).
McGuire, A.L. et al. To share or not to share: a randomized trial of consent for data sharing in genome research. Genet. Med. 13, 948–955 (2011).
Green, R.C., Lautenbach, D. & McGuire, A.L. GINA, genetic discrimination, and genomic medicine. N. Engl. J. Med. 372, 397–399 (2015).
Lacombe, D. et al. European perspective for effective cancer drug development. Nat. Rev. Clin. Oncol. 11, 492–498 (2014).
Conley, B.A. & Doroshow, J.H. Molecular analysis for therapy choice: NCI MATCH. Semin. Oncol. 41, 297–299 (2014).
Schilsky, R.L. Implementing personalized cancer care. Nat. Rev. Clin. Oncol. 11, 432–438 (2014).
Eggermont, A.M. et al. Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. Eur. J. Cancer 50, 2745–2746 (2014).
American Association for Cancer Research. Project GENIE (Genomics Evidence Neoplasia Information Exchange) http://www.aacr.org/Documents/GENIE_InfoGraph.pdf.
Acknowledgements
This manuscript is written on behalf of the GA4GH Clinical Working Group (WG). We thank the Data WG, Regulatory and Ethics WG and Security WG for their important contributions. L.L.S. is supported by the Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; M.L., C.C. and R.C.F. are supported by Cancer Research UK; D.H. is funded by the US National Institutes of Health (award #U54HG007990). B.M.K. is supported by the Quebec Breast Cancer Foundation; C.L.S. is supported by the Howard Hughes Medical Institute and US National Cancer Institute (Grant #CA008748); E.E.V. is supported by the Barcode for Life Foundation and the Hartwig Medical Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.C.B. is employed by AstraZeneca and is a stock owner of AstraZeneca. W.P. is employed by Roche, is a shareholder of Roche, has rights to EGFR T790M mutation testing (licensed to MolecularMD) and is a co-founder of MyCancerGenome. W.R.S. is employed by the Novartis Institute for Biomedical Research and is a shareholder of Novartis Pharma. C.L.S. serves on the Board of Novartis Pharma. All other authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Siu, L., Lawler, M., Haussler, D. et al. Facilitating a culture of responsible and effective sharing of cancer genome data. Nat Med 22, 464–471 (2016). https://doi.org/10.1038/nm.4089
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4089
This article is cited by
-
Delivering precision oncology to patients with cancer
Nature Medicine (2022)
-
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
Scientific Reports (2021)
-
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Nature Genetics (2020)
-
Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia
Human Genetics (2019)
-
Tensions in ethics and policy created by National Precision Medicine Programs
Human Genomics (2018)